Related Experiment Videos
[Hyperglycemic hyperosmolar nonketotic syndrome]
1Clinic of Intensive Care, Kaunas University of Medicine, Eiveniu 2, 3007 Kaunas, Lithuania.
Medicina (Kaunas, Lithuania)
|July 25, 2003
Summary
Hyperglycemic hyperosmolar nonketotic syndrome (HHNS) is a severe diabetes complication, primarily in type 2 patients, causing extreme dehydration and neurological issues. Early diagnosis and treatment, including fluid replacement and insulin therapy, are crucial for managing this life-threatening condition.
Area of Science:
- Endocrinology and Metabolism
- Diabetology
Context:
- Hyperglycemic hyperosmolar nonketotic syndrome (HHNS) is a critical acute complication of diabetes mellitus.
- Predominantly observed in type 2 diabetes patients, HHNS presents with severe dehydration and neurological symptoms linked to hyperosmolarity.
Purpose:
- To review precipitating factors, pathogenesis, and metabolic disturbances in HHNS.
- To discuss diagnostic procedures, laboratory evaluation, differential diagnosis, and treatment strategies for HHNS.
- To cover complication management, mortality rates, and prevention of HHNS.
Summary:
- This review synthesizes current data on HHNS, focusing on its etiology, pathophysiology, and metabolic derangements.
- It details diagnostic criteria, essential laboratory assessments, and differential diagnoses to distinguish HHNS from other hyperglycemic states.
- Treatment strategies emphasize fluid and electrolyte replacement alongside low-dose insulin therapy, with a focus on managing complications and reducing mortality.
Impact:
- Highlights the significant morbidity and mortality associated with HHNS despite advances in care.
- Provides a comprehensive overview for clinicians on the diagnosis and management of this diabetic emergency.
- Underscores the importance of understanding pathogenesis for effective prevention and treatment strategies.